Health & Saf. Code, § 11480.3 · Chapter 8. Seizure and Disposition
Health & Saf. Code, § 11480.3
Text — As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)
(a) The panel may withdraw approval from a research project for reasonable cause.
(b) Prior to withdrawing approval, the panel shall communicate its concerns in a written notice of pending withdrawal of approval to the head of the research project. The notice shall prescribe a course of action to address the concerns of the panel and provide a reasonable period in which to effect that cure.
(c) Approval may be reinstated once the concerns raised in the notice have been resolved to the reasonable satisfaction of the panel.
(d) Upon withdrawal of its approval, the panel shall notify the head of the research project to return or destroy any quantities of Schedule I or II controlled substances pursuant to any applicable state and federal regulations regarding the return or destruction of controlled substance research samples.
Notes and commentary — not statutory text
History
Added by Stats. 2025, Ch. 571, Sec. 7. (AB 1103) Effective January 1, 2026.
Source of truth
- Edition
- As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)
- Official file
- https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=HSC§ionNum=11480.3.
- Text hash
- sha256 c5fb8f3b064f17c570f9db3931293a61768ac2c5575a03f54aade3715b942a5d
- Composed by
- compose_ca.py 2026-10-22: the Legislative Counsel's CAML content files read by a tokenizer (caml_readers.reader_a); an independent xml.etree reading (caml_readers.reader_b) agrees on every section
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.